Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Gains from Investment Securities (2021 - 2026)

Axsome Therapeutics' Gains from Investment Securities history spans 6 years, with the latest figure at $672000.0 for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities rose 67.58% to $672000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $6.5 million, a 27.05% increase, with the full-year FY2025 number at $7.0 million, down 16.65% from a year prior.
  • Gains from Investment Securities hit $672000.0 in Q1 2026 for Axsome Therapeutics, down from $1.0 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for AXSM hit a ceiling of $9.2 million in Q1 2024 and a floor of $38000.0 in Q4 2023.
  • Historically, Gains from Investment Securities has averaged $1.7 million across 5 years, with a median of $700000.0 in 2023.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 96.8% in 2022 and later surged 11360.53% in 2024.
  • Tracing AXSM's Gains from Investment Securities over 5 years: stood at $163000.0 in 2022, then tumbled by 76.69% to $38000.0 in 2023, then surged by 11360.53% to $4.4 million in 2024, then crashed by 76.03% to $1.0 million in 2025, then plummeted by 35.63% to $672000.0 in 2026.
  • Business Quant data shows Gains from Investment Securities for AXSM at $672000.0 in Q1 2026, $1.0 million in Q4 2025, and $361938.0 in Q3 2025.